Helicobacter pylori infection
Conditions
Interventions
Control group:Quadruple therapy 14 days
Observation group A:Jianpi Huashi granule 28 days
Observation group B:Jianpi Huashi granule 14 days + quadruple therapy and Jianpi Huashi granule 14 days
Sponsors
Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-75 years old gender unlimited; (2) At least 2 months from the last eradication treatment withdrawal; (3) Positive urea breath test within 1 month before treatment; (4) The subjects gave their informed consent and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Antibiotics bismuth proton pump inhibitors (PPIs) or H2 receptor antagonists were used within 4 weeks before treatment Anti agent (H2RA); (2) Complicated with serious heart lung liver kidney malignant tumor and other diseases; (3) Complicated with serious anxiety depression schizophrenia and other mental diseases; (4) Pregnant or lactating women; (5) Previous allergy to relevant drugs in the treatment plan; (6) Participated in other drug research within 3 months before treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hp eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hp recurrence rate;Traditional Chinese medicine Symptom Score; | — |
Countries
China
Contacts
Public ContactFeng Jiang
Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Outcome results
None listed